Application of Jean-Paul and Martine Clozel regarding the exemption from the offer obligation in relation to Idorsia Ltd
July 29, 2021 01:00 ET | Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...
Application of Jean-Paul and Martine Clozel regarding the exemption from the offer obligation in relation to Idorsia Ltd
July 29, 2021 01:00 ET | Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...
Idorsia announces the reference share price and the initial conversion price of convertible bonds successfully placed today
July 28, 2021 12:33 ET | Idorsia Pharmaceuticals Ltd
NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE...
Idorsia announces the reference share price and the initial conversion price of convertible bonds successfully placed today
July 28, 2021 12:33 ET | Idorsia Pharmaceuticals Ltd
NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE...
Idorsia successfully completes the offering of convertible bonds, securing funding to develop the company into a leading biopharmaceutical company
July 28, 2021 09:56 ET | Idorsia Pharmaceuticals Ltd
NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE...
Idorsia successfully completes the offering of convertible bonds, securing funding to develop the company into a leading biopharmaceutical company
July 28, 2021 09:56 ET | Idorsia Pharmaceuticals Ltd
NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE...
Idorsia launches the offering of convertible bonds to fund the development of the company into a leading biopharmaceutical company
July 28, 2021 01:00 ET | Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...
Idorsia launches the offering of convertible bonds to fund the development of the company into a leading biopharmaceutical company
July 28, 2021 01:00 ET | Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...
Idorsia announces financial results for the first half 2021 – Building momentum towards becoming a fully-fledged biopharmaceutical company
July 27, 2021 01:01 ET | Idorsia Pharmaceuticals Ltd
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – July 27, 2021Idorsia Ltd (SIX: IDIA) today announced its financial results for the first half of 2021. Business highlights ...
Idorsia gibt Finanzergebnisse für das erste Halbjahr 2021 bekannt – Entwicklung zum vollständig integrierten biopharmazeutischen Unternehmen schreitet dynamisch voran
July 27, 2021 01:01 ET | Idorsia Pharmaceuticals Ltd
Ad hoc-Mitteilung gemäss Art. 53 KR Allschwil, Schweiz – 27. Juli 2021Idorsia Ltd (SIX: IDIA) veröffentlichte heute die Finanzergebnisse für das erste Halbjahr 2021. Operative Highlights ...